About Noblegen
Noblegen is a company based in Peterborough (Canada) founded in 2013 was acquired by SolarBiotech in July 2023. It operates as a Commission-Based. Noblegen has raised $18.51 million across 3 funding rounds from investors including HHS and SolarBiotech. Noblegen offers products and services including Online Slots. Noblegen operates in a competitive market with competitors including Novozymes, Evelo Biosciences, Seed, Seres Therapeutics and Enzymotec, among others.
- Headquarter Peterborough, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.51 M (USD)
in 3 rounds
-
Latest Funding Round
$18.51 M (USD), Series B
May 30, 2019
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
SolarBiotech
(Jul 25, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Noblegen
Noblegen offers a comprehensive portfolio of products and services, including Online Slots.
Online slots are provided with easy winning opportunities.
People of Noblegen
Unlock access to complete
Funding Insights of Noblegen
Noblegen has successfully raised a total of $18.51M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $18.51 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Noblegen
Noblegen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and SolarBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Modular plant architectures are produced for scaling laboratory equipment.
|
Locked | Locked | Locked |
Investor details for Noblegen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Noblegen
Investment portfolio details for Noblegen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Noblegen
Detailed financials for Noblegen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Noblegen Comparisons
Peer comparison for Noblegen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Noblegen
Noblegen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Evelo Biosciences, Seed, Seres Therapeutics and Enzymotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| Locked | Locked | Locked |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| Locked | Locked | Locked |
Synbiotics are developed for simulating the gut microbiome.
|
|
| Locked | Locked | Locked |
Microbiome therapeutics are developed to address diverse diseases.
|
|
| Locked | Locked | Locked |
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses.
|
|
| Locked | Locked | Locked |
Microbiome therapies are developed for treating intestinal dysbiosis diseases.
|
Detailed competitors of Noblegen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Noblegen
Complete news archive for Noblegen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Noblegen
Noblegen was founded in 2013.
Noblegen is headquartered in Peterborough, Canada. It is registered at Peterborough, Ontario, Canada.
Noblegen is a funded company, having raised a total of $18.51M across 3 funding rounds to date.
Noblegen is managed as a direct online slots platform offering gaming services without intermediaries. It is focused on the online gambling sector, providing a variety of slot games with high payout rates and bonuses. Solutions include seamless deposit and withdrawal systems using True Wallet, ensuring accessibility even for users with minimal capital. The platform is supported by a certified API system for transparency and security, catering to a wide range of players seeking entertainment and real money rewards.
Noblegen's top competitors include Novozymes, Seres Therapeutics and Seed.
Noblegen offers Online Slots.
Noblegen has 2 investors. Key investors include HHS, and SolarBiotech.